首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Knockdown of Asparagine Synthetase A Renders Trypanosoma brucei Auxotrophic to Asparagine
【2h】

Knockdown of Asparagine Synthetase A Renders Trypanosoma brucei Auxotrophic to Asparagine

机译:击倒天冬酰胺合成酶A使布鲁氏锥虫营养缺陷为天冬酰胺

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Asparagine synthetase (AS) catalyzes the ATP-dependent conversion of aspartate into asparagine using ammonia or glutamine as nitrogen source. There are two distinct types of AS, asparagine synthetase A (AS-A), known as strictly ammonia-dependent, and asparagine synthetase B (AS-B), which can use either ammonia or glutamine. The absence of AS-A in humans, and its presence in trypanosomes, suggested AS-A as a potential drug target that deserved further investigation. We report the presence of functional AS-A in Trypanosoma cruzi (TcAS-A) and Trypanosoma brucei (TbAS-A): the purified enzymes convert L-aspartate into L-asparagine in the presence of ATP, ammonia and Mg2+. TcAS-A and TbAS-A use preferentially ammonia as a nitrogen donor, but surprisingly, can also use glutamine, a characteristic so far never described for any AS-A. TbAS-A knockdown by RNAi didn't affect in vitro growth of bloodstream forms of the parasite. However, growth was significantly impaired when TbAS-A knockdown parasites were cultured in medium with reduced levels of asparagine. As expected, mice infections with induced and non-induced T. brucei RNAi clones were similar to those from wild-type parasites. However, when induced T. brucei RNAi clones were injected in mice undergoing asparaginase treatment, which depletes blood asparagine, the mice exhibited lower parasitemia and a prolonged survival in comparison to similarly-treated mice infected with control parasites. Our results show that TbAS-A can be important under in vivo conditions when asparagine is limiting, but is unlikely to be suitable as a drug target.
机译:天冬酰胺合成酶(AS)以氨或谷氨酰胺为氮源,催化ATP依赖性的天冬氨酸转化为天冬酰胺。 AS有两种截然不同的类型,即严格依赖氨的天冬酰胺合成酶A(AS-A)和可以使用氨或谷氨酰胺的天冬酰胺合成酶B(AS-B)。人体内AS-A的缺失及其在锥虫中的存在表明AS-A是潜在的药物靶标,值得进一步研究。我们报告了功能性AS-A在克氏锥虫(TcAS-A)和布鲁氏锥虫(TbAS-A)中的存在:纯化的酶在ATP,氨和Mg 2存在下将L-天冬氨酸转化为L-天冬酰胺+ 。 TcAS-A和TbAS-A优先使用氨作为氮供体,但令人惊讶的是,也可以使用谷氨酰胺,这是迄今从未针对任何AS-A描述的特性。 RNAi对TbAS-A的抑制作用不影响寄生虫血流形式的体外生长。但是,在天冬酰胺水平降低的培养基中培养TbAS-A击倒寄生虫时,生长会受到严重损害。不出所料,诱导和未诱导的布鲁氏菌RNAi克隆对小鼠的感染与野生型寄生虫相似。然而,当将诱导的布鲁氏菌RNAi克隆注射到进行过天冬酰胺酶处理的小鼠中后,该小鼠消耗了血液中的天冬酰胺,与感染了对照寄生虫的相似处理的小鼠相比,小鼠表现出较低的寄生虫血症和更长的生存期。我们的结果表明,当天冬酰胺受到限制时,TbAS-A在体内条件下可能很重要,但不太可能适合用作药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号